Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

PHASE2CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2009

Conditions
Breast CancerNeutropenia
Interventions
DRUG

AVI-014 versus Filgrastim

3 different dose arms of AVI-014 versus Filgrastim for up to 14 days daily

Trial Locations (31)

10096

Dharamshila Hospital and research Centre, Vasundhara Enclave

24211

Cancer Outreach Associates PC, Abingdon

29801

Cancer Care Institute of Carolina, Aiken

32713

Physicians Research Alliance LLC., DeBary

44781

Gabrail Cancer Center, Canton

45042

Signal Point Clinical Research Center, LLC, Middletown

62801

Southern Illinois Hematology/Oncology, Centralia

73104

University of Oklahoma Health Sciences Ctr, Oklaoma City

78412

Cancer Specialists of South Texas, Corpus Christi

90027

Ghassan Al-Jazayrly, MD, Inc., Los Angeles

91307

Infosphere Clinical Research, West Hills

91790

Brian LeBerthon, MD, A Medical Corporation, West Covina

92270

Desert Hematology Oncology Medical Group, Rancho Mirage

92801

Pacific Cancer Medical Center, Anaheim

110029

IRCH, AIIMS, Ansari Nagar,, New Delhi

110076

Indraprastha Apollo Hospital, Delhi Mathura Road, Sarita Vihar

King George Hospital, Vizag

110096

Dharamshila Cancer Center, Dharamshila Marg, Vasundhara Enclave

141001

Dayanand Medical College and Hospital, Tagore Nagar, Civil Lines

141009

Mohan Dai Oswal Cancer Treatment & Research Foundation, G.T. Road, Sherpur Bye Pass

411001

Ruby Hall Clinic, 40 Sasoon Road

462001

Jawaharlal Nehru Cancer Hospital and Research Centre, Idgah Hills

500033

Apollo Hospitals Educational and Research Foundation, Jubilee Hills

576104

Kasturba Medical College Hospital, Attavar

625107

Meenakshi Mission Hospital and Research Centre, Lake Area, Melur Road

682026

Amrita Institute of Medical Sciences, Amrita Lane Elamakkara

800014

Regional Cancer Centre, IGIMS, Sheikhpura

94904-2007

California Cancer Center, Greenbrae

600 035

Apollo Specialty Hospital, Padma Complex, 320 Mount Road

560 029

Kidwai Memorial Institute of Oncology, Dr. M.H. Marigowda Road, Bangalore

400 012

Tata Memorial Hospital,, Dr. E Borges Road, Parel

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AviGenics

INDUSTRY

NCT00497809 - Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | Biotech Hunter | Biotech Hunter